Safety of a Fixed-Dose Combination of Fenofibrate/Pravastatin 160 mg/40 mg in Patients with Mixed Hyperlipidaemia: A Pooled Analysis from a Database of Clinical Trials

Author: Farnier Michel  

Publisher: Adis International

ISSN: 1173-2563

Source: Clinical Drug Investigation, Vol.32, Iss.4, 2012-04, pp. : 281-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content